HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 16
HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CODELIFE. The owner is based in XIAMEN, FUJIAN PROVINCE.
ROOM 901-1, BUILDING C, LUOPUTE, NO. 188-2 FENGQI ROAD, PHASE III
SOFTWARE PARK, XIAMEN TORCH HIGH-TECH ZONE,
XIAMEN, FUJIAN PROVINCE 361022 , CN
Showing of trademarks Trademarks
Trademark Classifications
HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD. have?
HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD. file in?
HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 30 (Staple Foods). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.
What are HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD.'s most well-known trademarks?
HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as CODELIFE. These are among 1 currently registered trademark in the portfolio.
What is HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD.'s trademark registration success rate?
HAOJI (XIAMEN) CROSS-BORDER TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.